86 results
10-K
2022 FY
EX-10.20
OBSVF
ObsEva SA
31 Mar 23
Annual report
4:01pm
and reasonably acceptable to Buyer, for the sole purpose of verifying the accuracy of any payments due under this Agreement. Once examined, such records
10-K
2022 FY
OBSVF
ObsEva SA
31 Mar 23
Annual report
4:01pm
payment or offering of anything of value, directly or indirectly, to any foreign official, political party, or candidate for the purpose of influencing any … financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting
F-3
OBSVF
ObsEva SA
9 Dec 22
Shelf registration (foreign)
7:06am
for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform … offered pursuant to this prospectus for any purpose. Pending application of the net proceeds as described above, we may initially invest the net proceeds
F-3
EX-4.2
OBSVF
ObsEva SA
9 Dec 22
Shelf registration (foreign)
7:06am
or names a particular Security is registered on the Security Register kept for that purpose in accordance with the terms of this Indenture.
“Security … is legal tender for public and private debt, at the office or agency of the Company maintained for that purpose. Each Security shall be dated the date
F-3
EX-5.1
OBSVF
ObsEva SA
9 Dec 22
Shelf registration (foreign)
7:06am
”) to be supplemented by one or more prospectus supplements (each a “Prospectus Supplement” and each together with the Base Prospectus, a “Prospectus”) for the purpose …
REVIEWED DOCUMENTS
For the purpose of giving this opinion, we have only examined the following documents (the “Documents”):
a draft of the Registration
F-3
EX-4.1
bg9q23d3329hqclw1
9 Dec 22
Shelf registration (foreign)
7:06am
F-3MEF
230ns5yawhfdkbj4
3 Aug 22
Registration statement to add securities to prior F-3 registration
4:25pm
F-3MEF
EX-5.1
0nhlt gfoo0
3 Aug 22
Registration statement to add securities to prior F-3 registration
4:25pm
6-K
EX-99.1
d4vd32z
25 Apr 22
ObsEva Announces Confirmation of Positive CHMP Opinion for Linzagolix, an Oral GnRH
7:00am
6-K
EX-99.1
71cw 30lz
7 Apr 22
ObsEva Annual General Meeting 2022
7:01am
424B7
u0ag98 n0d
3 Mar 22
Prospectus with selling stockholder info
4:43pm
S-8
8922pma9bsgtvd56 u2d
2 Mar 22
Registration of securities for employees
4:48pm
S-8
bkh0xgs
2 Mar 22
Registration of securities for employees
4:48pm
F-3/A
EX-5.1
714 pk83r
25 Feb 22
Shelf registration (foreign) (amended)
8:52am
F-3/A
41lfax 9ng32vm53s6
25 Feb 22
Shelf registration (foreign) (amended)
8:52am
F-3
EX-5.1
qsy16eh
17 Feb 22
Shelf registration (foreign)
4:14pm